Max-Planck-Gesellschaft

What Max-Planck-Gesellschaft does

Max-Planck-Gesellschaft, operating through its Max Planck Institute for Terrestrial Microbiology (MPI-TM), is a German non-profit research organization headquartered in Marburg that conducts fundamental and applied research in molecular and synthetic microbiology. Founded in 1948 as part of the broader Max Planck Society network of over 86 institutes, MPI-TM investigates microbial metabolism of greenhouse gases, biosynthesis of bioactive natural compounds, cellular communication and regulation networks, and synthetic biological approaches to engineer microorganisms. The institute operates three research departments (Biochemistry and Synthetic Metabolism led by Tobias Erb; Natural Products in Organismic Interactions led by Helge Bode; Systems and Synthetic Microbiology led by Victor Sourjik), multiple Max Planck Research Groups, and department-independent groups, employing over 300 researchers from more than 35 countries.

The institute's core technology platforms center on proprietary enzyme and pathway engineering, including Fe nitrogenase for light-driven CO2 reduction to formate and methane, synthetic carboxylation modules and the Lactyl-CoA mutase (developed via adaptive laboratory evolution with 5-10x performance gains over natural precursors), the XUT cross-unit technology for assembling NRPS/PKS hybrid natural products such as syrbactins, and high-throughput synthetic biology pipelines supported by the MaxGENESYS biofoundry and core facilities in flow cytometry, mass spectrometry, metabolomics, and NMR. Research outputs are distributed through peer-reviewed publications in top-tier journals, technology transfer projects (HAPPY, DynaPore), the pan-European SynCell-nExUs postdoctoral program, and shared core facility services for external researchers.

MPI-TM operates under a non-profit, publicly funded business model. It receives core institutional support from the Max Planck Society, jointly financed by German federal and state governments, supplemented by competitive third-party grants from the European Research Council (ERC Advanced and Starting Grants), the Hessian LOEWE excellence program (4.78M EUR for the 2023-2026 Tree-M project), the Human Frontiers Science Program, and other scientific foundations. Revenue is not commercially generated through product or service sales; core facility access and transfer projects represent quasi-applied revenue channels rather than commercial monetization. The institute does not pursue an IPO and has no private shareholders, with strategic direction oriented toward scientific output, talent development, and translational research outcomes rather than financial returns.

Name

Max-Planck-Gesellschaft

Legal name

Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.

Website

https://mpi-marburg.mpg.de

Company type

Private

Founded year

1948

Operating status

Operating

Headcount range

101–250 employees

Short description

The Max Planck Institute for Terrestrial Microbiology (MPI-TM), part of the Max-Planck-Gesellschaft, is a publicly funded research institute in Marburg, Germany, employing 300+ researchers across molecular and synthetic microbiology, with proprietary enzyme technologies for CO2 fixation and natural product biosynthesis serving academic and industry collaborators.

Ownership category

akta.pro rank

Product category

Microbiology Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Microbiome & Metagenomics Services (HLAGANAH)

akta.pro secondary industries

Engineered Microbial Therapeutics (synthetic biology, gene circuits) (HLAAAFAD), Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC), Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF)

Keywords

• Molecular microbiology research
• Synthetic biology research
• Natural product biosynthesis
• Microbial metabolism studies
• Biofoundry services

Headquarters

HQ city

Marburg

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Government Funding: Funded by the Max Planck Society and German federal/state government research funding programs including LOEWE (Hessian excellence program)
2. European Research Council Grants: ERC Advanced Grant and ERC Starting Grant funding for specific research projects
3. Third-party Research Funding: Funding from programs like LOEWE (4.78 million euros for Tree-M project), Human Frontiers Science Grant, and other international research programs

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

The Max Planck Institute for Terrestrial Microbiology conducts basic research on molecular and synthetic microbiology spanning microbial metabolism of greenhouse gases, bioactive natural compounds, cellular communication, and synthetic biology approaches. Its externally accessible offering is centered on shared core facility services (Flow Cytometry & Imaging, Mass Spectrometry & Proteomics, Metabolomics, NMR, MaxGENESYS biofoundry) used by academic and industry collaborators, complemented by research training programs.

Product overview

The Max Planck Institute for Terrestrial Microbiology (MPI-TM) is a leading European research institute in molecular and synthetic microbiology, not a commercial product company. Its offerings consist of shared research infrastructure (Core Facilities) providing specialized scientific services, research programs, and educational initiatives. Core facilities include Flow Cytometry & Imaging, Mass Spectrometry & Proteomics, Metabolomics & Small Molecules MS, Natural Product Isolation and NMR, MaxGENESYS high-throughput biofoundry, and SYNMIKRO Facilities. The institute operates transfer projects (HAPPY, DynaPore), participates in the Microbes for Climate (M4C) Cluster of Excellence, and hosts the Microcosm Earth Center (MEC) jointly with Philipps University of Marburg. Educational offerings include the IMPRS graduate school for doctoral training.

Differentiator

Problem solved

Functional benefit

Brands

• SYNMIKRO: Center for Synthetic Microbiology - an interdisciplinary research center affiliated with Philipps University of Marburg
• Microcosm Earth Center (MEC)
• Microbes for Climate (M4C)

Products and services

• Flow Cytometry & Imaging Flow cytometry and microscopy imaging services for microbial cell analysis, available to external academic and industry researchers as a shared Core Facility.
• Mass Spectrometry & Proteomics Mass spectrometry-based proteomics and protein analysis services available to external researchers through the institute's Core Facilities.
• Metabolomics & Small Molecules MS Metabolomics analysis and small molecule mass spectrometry services accessed by internal and external researchers for microbial and biochemical studies.
• Natural Product Isolation and NMR NMR-based isolation and structural characterization of natural products, supporting microbial drug discovery efforts run by internal and external research groups.
• MaxGENESYS biofoundry High-throughput screening biofoundry platform providing automated workflows for synthetic biology and metabolic engineering research projects.

Quantifiable outcome

• Development of new-to-nature carboxylation module improving CO2 fixation efficiency
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Twelve partnerships are on record, tiered core, major and minor.

• Max Planck Institute of BiochemistrycoreStrategic or Co-development Partner · 1 August 2026Co-coordinator of SynCell-nExUs pan-European postdoctoral program offering 40 postdoctoral positions across 22 research institutions in 9 European countries starting August 1, 2026 for a duration of 5 years.
• Philipps-Universität MarburgcoreStrategic or Co-development PartnerLong-standing collaboration through SYNMIKRO (Center for Synthetic Microbiology), Microcosm Earth Center (MEC), and Microbes for Climate (M4C) Cluster of Excellence. Joint projects include Tree-M LOEWE focus and multiple research groups.
• SYNMIKRO (Center for Synthetic Microbiology)coreStrategic or Co-development PartnerAffiliated center dedicated to synthetic microbiology research, providing interdisciplinary cooperation hub in Marburg's microbiological research landscape.
• Microcosm Earth Center (MEC)coreStrategic or Co-development PartnerFuture Center addressing current issues of environmental and climate microbiology with 7-year initial duration, financially supported by the state of Hesse. Coordinates with Max Planck Institute and hosts multiple research groups.
• Justus-Liebig Universität GießenmajorStrategic or Co-development PartnerProject partner in LOEWE Tree-M priority (4.78 million euros funding 2023-2026) investigating leaf microbiome of trees for sustainable forest conservation strategies.
• Max Planck Institute for Molecular Plant Physiology (Potsdam)majorStrategic or Co-development PartnerCollaboration on Lactyl-CoA mutase research for new-to-nature CO2-dependent acetyl-CoA assimilation, published in Nature Communications.
• TU MunichmajorStrategic or Co-development PartnerCollaboration with Prof. Groll on XUT technology and immunoproteasome research for developing selective drug candidates against immune disorders using syrbactin-based hybrids.
• University of Duisburg-EssenmajorStrategic or Co-development PartnerCollaboration with Prof. Kaiser on synthetic biology approaches for drug development and natural product engineering.
• Max Planck Institute for Marine Microbiology (Bremen)majorStrategic or Co-development PartnerSister institute collaboration; Dr. Judith Klatt previously worked there before establishing research group at Microcosm Earth Center. Ongoing scientific exchange in marine and environmental microbiology.
• University of Wisconsin-MadisonminorStrategic or Co-development PartnerJoint research on RNA biology through Campus Focus 'Microorganisms and Viruses' of Central Hesse Research Campus.
• Chinese Academy of SciencesmajorStrategic or Co-development PartnerMax Planck-Chinese Academy Center for Synthetic Biochemistry established for natural product research collaboration with Chinese partners.
• 22 European Research InstitutionsmajorStrategic or Co-development PartnerParticipating institutions in SynCell-nExUs program across 9 European countries, including leading universities and research centers in synthetic biology.

Scale indicators6 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• ETH Zurich Department of Biology: Leading European research university with strong synthetic biology and microbiology programs. Competes directly with MPI-TM for ERC funding, faculty recruitment, and top-tier publication output in molecular microbiology and CO2 fixation.
• European Molecular Biology Laboratory (EMBL): Intergovernmental research organization in molecular life sciences with overlapping research in synthetic biology, structural biology, and microbial genomics. Comparable funding model and European scientific mission.
• Institut Pasteur: Leading French non-profit research institute with deep programs in microbiology, infectious disease, and molecular biology. Competes with MPI-TM for European funding, EMBO-affiliated talent, and high-impact publications.
• Weizmann Institute of Science: Israeli research university with strong departments in biochemistry, molecular genetics, and microbial sciences. Comparable in scale, mission, and research output to MPI-TM, often publishing in the same top-tier journals.
• Broad Institute: US-based joint Harvard-MIT institute with significant synthetic biology and microbiome research programs. Competes globally for talent, grants, and high-impact publications in molecular biology and engineering biology.
• MRC Laboratory of Molecular Biology: UK-based government research laboratory with foundational contributions to molecular biology and synthetic biology. Competes with MPI-TM for top-tier scientific talent and breakthrough publications.
• Max Planck Institute of Biochemistry: Sister Max Planck institute in Martinsried, co-coordinator of the SynCell-nExUs postdoctoral program. Operates overlapping research in molecular biology, biochemistry, and synthetic biology, sharing talent pipelines and infrastructure.

Others

• Novonesis (Novozymes): Industrial biotechnology company that commercializes enzymes and microbial solutions at scale. Represents the commercial translation pathway for academic discoveries in enzyme engineering and synthetic metabolism from MPI-TM.

Emerging players

• Joint BioEnergy Institute (JBEI): DOE-funded US research institute focused on synthetic biology for biofuels and bioproducts, with overlapping research on CO2 utilization and engineered metabolism. Represents a more application-oriented research model.

Broad incumbents

• Scripps Research Institute: Large US non-profit research organization with broad programs in chemistry, biology, and translational medicine. Has overlapping capabilities in natural product discovery and synthetic biology but operates a much wider research portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/marinemicrobio
• LinkedInlinkedin.com/company/max-planck-institute-for-terrestrial-microbiology
• Facebookfacebook.com/maxplancksociety

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Max-Planck-Gesellschaft